OrganiGram Holdings Inc. (OGI)
USD 1.47
(-8.7%)
USD 1.47
(-8.7%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 80.95 Million CAD | 18.56% |
| 2022 | 68.28 Million CAD | 39.87% |
| 2021 | 48.81 Million CAD | -31.97% |
| 2020 | 71.75 Million CAD | -36.94% |
| 2019 | 113.79 Million CAD | 75.54% |
| 2018 | 64.82 Million CAD | 1099.21% |
| 2017 | 5.4 Million CAD | -14.3% |
| 2016 | 6.3 Million CAD | 176.76% |
| 2015 | 2.27 Million CAD | 1400.18% |
| 2014 | 151.92 Thousand CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 81.23 Million CAD | 0.35% |
| 2024 Q3 | 84.07 Million CAD | 0.98% |
| 2024 Q2 | 83.26 Million CAD | 2.5% |
| 2023 Q3 | 81.83 Million CAD | -7.7% |
| 2023 Q1 | 87.21 Million CAD | 27.72% |
| 2023 Q2 | 88.65 Million CAD | 1.66% |
| 2023 FY | 80.95 Million CAD | 18.56% |
| 2023 Q4 | 80.95 Million CAD | -1.07% |
| 2022 Q1 | 46.42 Million CAD | -4.91% |
| 2022 Q2 | 56.18 Million CAD | 21.04% |
| 2022 Q3 | 60.57 Million CAD | 7.82% |
| 2022 FY | 68.28 Million CAD | 39.87% |
| 2022 Q4 | 68.28 Million CAD | 12.72% |
| 2021 Q2 | 43.37 Million CAD | -19.56% |
| 2021 Q3 | 46.63 Million CAD | 7.53% |
| 2021 Q4 | 48.81 Million CAD | 4.67% |
| 2021 FY | 48.81 Million CAD | -31.97% |
| 2021 Q1 | 53.92 Million CAD | -24.86% |
| 2020 Q3 | 100.63 Million CAD | -28.54% |
| 2020 Q2 | 140.83 Million CAD | 12.48% |
| 2020 Q1 | 125.2 Million CAD | 10.03% |
| 2020 Q4 | 71.75 Million CAD | -28.69% |
| 2020 FY | 71.75 Million CAD | -36.94% |
| 2019 Q4 | 113.79 Million CAD | -0.39% |
| 2019 FY | 113.79 Million CAD | 75.54% |
| 2019 Q3 | 114.23 Million CAD | -0.64% |
| 2019 Q2 | 114.96 Million CAD | -2.39% |
| 2019 Q1 | 117.78 Million CAD | 81.69% |
| 2018 Q4 | 64.82 Million CAD | 141.09% |
| 2018 FY | 64.82 Million CAD | 1099.21% |
| 2018 Q1 | 7.14 Million CAD | 32.18% |
| 2018 Q2 | 13.31 Million CAD | 86.3% |
| 2018 Q3 | 26.88 Million CAD | 102.0% |
| 2017 Q1 | 6.05 Million CAD | -3.93% |
| 2017 Q2 | 5.58 Million CAD | -7.77% |
| 2017 FY | 5.4 Million CAD | -14.3% |
| 2017 Q3 | 4.49 Million CAD | -19.54% |
| 2017 Q4 | 5.4 Million CAD | 20.21% |
| 2016 FY | 6.3 Million CAD | 176.76% |
| 2016 Q3 | 4.93 Million CAD | 29.09% |
| 2016 Q2 | 3.82 Million CAD | 42.29% |
| 2016 Q1 | 2.68 Million CAD | 17.88% |
| 2016 Q4 | 6.3 Million CAD | 27.82% |
| 2015 Q1 | 268.87 Thousand CAD | 76.98% |
| 2015 FY | 2.27 Million CAD | 1400.18% |
| 2015 Q4 | 2.27 Million CAD | 36.98% |
| 2015 Q3 | 1.66 Million CAD | 146.31% |
| 2015 Q2 | 675.52 Thousand CAD | 151.24% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q4 | 151.92 Thousand CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 FY | 151.92 Thousand CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Theratechnologies Inc. | 6.06 Million USD | -1234.537% |
| Harrow Health, Inc. | 10.86 Million USD | -644.943% |
| Dynavax Technologies Corporation | 53.29 Million USD | -51.91% |
| Biofrontera Inc. | 10.9 Million USD | -642.143% |
| Cronos Group Inc. | 30.33 Million USD | -166.828% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -2877.308% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -8095299900.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | -1320.469% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -1656.273% |
| Radius Health, Inc. | 278.64 Million USD | 70.947% |
| Universe Pharmaceuticals INC | 3.34 Million USD | -2321.375% |
| DURECT Corporation | 2.21 Million USD | -3548.175% |
| ProPhase Labs, Inc. | 3.84 Million USD | -2007.602% |
| Safety Shot Inc | 1.86 Million USD | -4229.855% |
| Phibro Animal Health Corporation | 265.91 Million USD | 69.556% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -9897.197% |
| Alvotech | 74.43 Million USD | -8.76% |
| Assertio Holdings, Inc. | 37.68 Million USD | -114.809% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | -4.58% |
| Rockwell Medical, Inc. | 5.87 Million USD | -1278.862% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -1311.621% |
| Procaps Group S.A. | 96.83 Million USD | 16.399% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | -595.055% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| Aytu BioPharma, Inc. | 12.63 Million USD | -540.806% |
| Viatris Inc. | 3.46 Billion USD | 97.667% |
| OptiNose, Inc. | 8.05 Million USD | -905.378% |
| SIGA Technologies, Inc. | 64.21 Million USD | -26.059% |
| Tilray Brands, Inc. | 252.08 Million USD | 67.887% |
| PetIQ, Inc. | 159.3 Million USD | 49.185% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -1311.621% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | -111.366% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | -2923.893% |
| Alimera Sciences, Inc. | 1.87 Million USD | -4208.302% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | -150.38% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Organogenesis Holdings Inc. | 28.25 Million USD | -186.529% |
| Journey Medical Corporation | 10.2 Million USD | -693.19% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | -4926.916% |
| Alpha Teknova, Inc. | 11.59 Million USD | -598.232% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | -1705.777% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | -102.489% |
| PainReform Ltd. | - USD | -Infinity% |
| Cosmos Health Inc. | 4.78 Million USD | -1590.376% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | -679.894% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Embecta Corp. | 152.1 Million USD | 46.776% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 53087.341% |
| Talphera, Inc. | - USD | -Infinity% |
| Pacira BioSciences, Inc. | 104.35 Million USD | 22.424% |
| Incannex Healthcare Limited | -10.01 Million USD | 908.318% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -31727.153% |
| Shineco, Inc. | 1.58 Million USD | -4996.111% |
| Procaps Group, S.A. | 96.83 Million USD | 16.399% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | 27.198% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | -1095.937% |
| Lantheus Holdings, Inc. | 64.02 Million USD | -26.432% |
| Alvotech | 74.43 Million USD | -8.76% |
| Hempacco Co., Inc. | 2.54 Million USD | -3083.832% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | -69.379% |
| Bright Green Corporation | - USD | -Infinity% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | -23.361% |
| Kamada Ltd. | 87.74 Million USD | 7.742% |
| Indivior PLC | 141.79 Million USD | 42.91% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -16700.805% |
| Flora Growth Corp. | 8.5 Million USD | -851.493% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -31727.153% |
| Evolus, Inc. | 10.99 Million USD | -636.07% |
| HUTCHMED (China) Limited | 50.25 Million USD | -61.075% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 23.509% |
| Akanda Corp. | 1.28 Million USD | -6190.572% |